AME.NYSEAmetek Inc/

Form 4: AMETEK Exec Ciampitti Boosts Stake with Stock, Options

Sentiment:

Insider Transaction Report


AMETEK's President of Electronic Instruments, Tony J. Ciampitti, acquired 1,300 restricted common shares and 4,110 stock options, while also disposing of 229 shares for tax withholding.

Summary

  • Tony J. Ciampitti, President of Electronic Instruments at AMETEK Inc. (AME), reported transactions on March 18, 2026.
  • Acquired 1,300 shares of common stock at $212.77 per share, issued as restricted stock under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.
  • Disposed of 229 shares of common stock at $212.77 per share to cover tax withholding obligations.
  • Acquired 4,110 stock options with an exercise price of $212.77 per share.
  • The stock options will become exercisable in three equal annual installments starting March 18, 2027, and expire on March 18, 2036.
  • Following these transactions, Ciampitti directly owns 56,189 shares of common stock and 4,110 stock options.
  • Indirect holdings include 9,465 shares in a Serp plan and 2,776 shares in a 401k plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies continued executive commitment through equity grants and options, aligning management's financial interests with the company's long-term performance.

Positives

  • Acquisition of 1,300 restricted common shares demonstrates continued equity ownership and alignment with shareholder interests.
  • Grant of 4,110 stock options provides a long-term incentive for management performance, aligning executive compensation with future stock price appreciation.

Negatives

  • Disposal of 229 shares for tax withholding, while a standard practice, slightly reduces direct share ownership.

Future Outlook

The acquired stock options will vest in three equal annual installments beginning March 18, 2027, indicating a long-term incentive structure for the reporting person.

Industry Context

StockSavvy.ai notes that executive equity grants and option awards are standard practices across industries to align management incentives with shareholder value creation. This filing reflects a routine compensation event for a senior executive at AMETEK.

Stakeholder Impact

  • Shareholders: The transactions align the interests of a key executive with shareholders, potentially fostering long-term value creation.
  • Employees: Reflects standard executive compensation practices within the company.

Next Steps

  • The acquired stock options will begin to vest in three equal annual installments starting March 18, 2027.

Key Dates

DateDescription
03/18/2026Date of reported transactions for common stock and stock options.
03/19/2026Date the Form 4 was signed by Lynn Carino, attorney-in-fact for Mr. Ciampitti.
03/18/2027First date the acquired stock options become exercisable (first of three equal annual installments).
03/18/2036Expiration date of the acquired stock options.

Recommendation

hold

This Form 4 filing details routine executive compensation in the form of restricted stock and stock options, along with a standard tax-related disposition. While it shows continued alignment of executive interests with the company, it does not present new information that would fundamentally alter the investment thesis for AMETEK. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

AMETEK, AME, Insider Trading, Form 4, Stock Options, Restricted Stock, Executive Compensation, Tony J. Ciampitti, Equity Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.